117 related articles for article (PubMed ID: 8534045)
21. INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status.
Eriksson M; Bolme P; Habte D; Paalzow L
Acta Paediatr Scand; 1988 Nov; 77(6):890-4. PubMed ID: 3144828
[TBL] [Abstract][Full Text] [Related]
22. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations.
Agrawal S; Singh I; Kaur KJ; Bhade SR; Kaul CL; Panchagnula R
Int J Clin Pharmacol Ther; 2002 Oct; 40(10):474-81. PubMed ID: 12395981
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of isoniazid in moderately malnourished children with tuberculosis.
Roy V; Gupta D; Gupta P; Sethi GR; Mishra TK
Int J Tuberc Lung Dis; 2010 Mar; 14(3):374-6. PubMed ID: 20132632
[TBL] [Abstract][Full Text] [Related]
24. Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis.
Mitchison DA
Am J Respir Crit Care Med; 2003 May; 167(10):1298-9. PubMed ID: 12738593
[No Abstract] [Full Text] [Related]
25. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis on high dose isoniazid: reintroduction of the drug in severe tuberculous meningitis.
Danielides IC; Constantoulakis M; Daikos GK
Am J Gastroenterol; 1983 Jun; 78(6):378-80. PubMed ID: 6859018
[TBL] [Abstract][Full Text] [Related]
27. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY
Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254
[TBL] [Abstract][Full Text] [Related]
28. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India.
Ranjalkar J; Mathew SK; Verghese VP; Bose A; Rose W; Gupta D; Fleming DH; Mathew BS
Int J Antimicrob Agents; 2018 May; 51(5):663-669. PubMed ID: 29241821
[TBL] [Abstract][Full Text] [Related]
29. Plasma concentrations of isoniazid in children with tuberculous infections.
Olson WA; Pruitt AW; Dayton PG
Pediatrics; 1981 Jun; 67(6):876-8. PubMed ID: 7232051
[TBL] [Abstract][Full Text] [Related]
30. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine.
Weiner M; Burman W; Vernon A; Benator D; Peloquin CA; Khan A; Weis S; King B; Shah N; Hodge T;
Am J Respir Crit Care Med; 2003 May; 167(10):1341-7. PubMed ID: 12531776
[TBL] [Abstract][Full Text] [Related]
31. Tuberculous meningitis: is a 6-month treatment regimen sufficient?
van Loenhout-Rooyackers JH; Keyser A; Laheij RJ; Verbeek AL; van der Meer JW
Int J Tuberc Lung Dis; 2001 Nov; 5(11):1028-35. PubMed ID: 11716339
[TBL] [Abstract][Full Text] [Related]
32. Isoniazid and acetylisoniazid kinetics in serum and urine in pulmonary primary complex with intermittent regimen.
Seth V; Seth SD; Beotra A; Semwal OP; D'monty V; Mukhopadhya S
Indian Pediatr; 1994 Mar; 31(3):279-85. PubMed ID: 7896362
[TBL] [Abstract][Full Text] [Related]
33. Effect of dose formulation on isoniazid absorption in two young children.
Notterman DA; Nardi M; Saslow JG
Pediatrics; 1986 Jun; 77(6):850-2. PubMed ID: 3086830
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
36. Rifapentine for the treatment of tuberculosis: is it all it can be?
Gordin FM
Am J Respir Crit Care Med; 2004 Jun; 169(11):1176-7. PubMed ID: 15161608
[No Abstract] [Full Text] [Related]
37. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
Parkin DP; Vandenplas S; Botha FJ; Vandenplas ML; Seifart HI; van Helden PD; van der Walt BJ; Donald PR; van Jaarsveld PP
Am J Respir Crit Care Med; 1997 May; 155(5):1717-22. PubMed ID: 9154882
[TBL] [Abstract][Full Text] [Related]
38. A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Harada M; Kajiki A
J Infect Chemother; 2011 Oct; 17(5):689-93. PubMed ID: 21327690
[TBL] [Abstract][Full Text] [Related]
39. Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction.
Nakatani Y; Suto Y; Fukuma K; Yamawaki M; Sakata R; Takahashi S; Nakayasu H; Nakashima K
Intern Med; 2017; 56(8):953-957. PubMed ID: 28420846
[TBL] [Abstract][Full Text] [Related]
40. Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy.
Al-Dossary FS; Ong LT; Correa AG; Starke JR
Pediatr Infect Dis J; 2002 Feb; 21(2):91-7. PubMed ID: 11840073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
